TY - CHAP
T1 - Apoptosis in leukemias
T2 - Regulation and therapeutic targeting
AU - Samudio, Ismael
AU - Konopleva, Marina
AU - Carter, Bing
AU - Andreeff, Michael
PY - 2010
Y1 - 2010
N2 - Nearly 25 years after the seminal publication of John Foxton Kerr that first described apoptosis, the process of regulated cell death, our understanding of this basic physiological phenomenon is far from complete [39]. From cardiovascular disease to cancer, apoptosis has assumed a central role with broad ranging therapeutic implications that depend on a complete understanding of the molecular events involved in orchestrating cellular demise. More than 145,301 (as of April 2008) published works on this subject have increased our understanding of this process, yet have also identified an incredibly complex regulatory system that is critical for development and is at the core of many diseases, challenging scientists and clinicians to step into its molecular realm and modulate its circuitry for therapeutic purposes. This chapter will review our understanding of the molecular circuitry that controls apoptosis in leukemia and the pharmacological manipulations of this pathway that may yield therapeutic benefit.
AB - Nearly 25 years after the seminal publication of John Foxton Kerr that first described apoptosis, the process of regulated cell death, our understanding of this basic physiological phenomenon is far from complete [39]. From cardiovascular disease to cancer, apoptosis has assumed a central role with broad ranging therapeutic implications that depend on a complete understanding of the molecular events involved in orchestrating cellular demise. More than 145,301 (as of April 2008) published works on this subject have increased our understanding of this process, yet have also identified an incredibly complex regulatory system that is critical for development and is at the core of many diseases, challenging scientists and clinicians to step into its molecular realm and modulate its circuitry for therapeutic purposes. This chapter will review our understanding of the molecular circuitry that controls apoptosis in leukemia and the pharmacological manipulations of this pathway that may yield therapeutic benefit.
UR - http://www.scopus.com/inward/record.url?scp=77956160814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956160814&partnerID=8YFLogxK
U2 - 10.1007/978-0-387-69259-3_12
DO - 10.1007/978-0-387-69259-3_12
M3 - Chapter
C2 - 20306253
AN - SCOPUS:77956160814
SN - 9780387692579
T3 - Cancer Treatment and Research
SP - 197
EP - 217
BT - Acute Myelogenous Leukemia
A2 - Nagarajan, Lalitha
ER -